| Literature DB >> 27051564 |
Maria Regina Rachmawati1, Angela B M Tulaar2, Suzana Immanuel3, A Purba4, Muchtaruddin Mansyur5, Ratna Darjanti Haryadi6, Ismail Hadisoebroto7, Amin Husni8, Nurhadi Ibrahim9.
Abstract
Biomechanical abnormalities of pronated feet accompanied by functional leg length disparity may increase the risk of skeletal muscle injury. Objective of the study is to prove that correction of pronated feet by the foot orthoses will reduce the creatine kinase-MM (CK-MM) concentrations as the muscle injury indicator. The design study was double blind randomized clinical trials with control. Research subjects were divided into two groups, group 1 used the foot orthoses while group 2 did not used the foot orthoses. The whole subject examined the concentrations of the CK-MM enzyme before, and 24-72 hours after the walking test. The walking test was conducted 15 minutes with maximum speed. The concentration of the CK-MM enzyme before walking test on treatment group was 70.07±15.33 International Unit (IU), similar with the control group was 69.85±17.03 IU (P=0.971). The increased in CK-MM enzyme concentrations 45 hours after the walking test was lower in the treatment group (7.8±9 IU) than the control group (22.0±11.5 IU) (P=0.001). The CK-MM enzyme concentrations continued to decline in the treatment group after the second walking test (77.21±17.47 IU), and after the third walking test (69.86±11.88 IU) (P=0.018). The foot orthoses for correcting the pronated feet on the young women with biomechanical abnormalities is able to reduce the degree of the skeletal muscle injury after walking activity.Entities:
Keywords: Biomechanical abnormalities; Creatine kinase-MM; Foot orthoses; Muscle injury; Pronated feet
Year: 2016 PMID: 27051564 PMCID: PMC4819074 DOI: 10.5115/acb.2016.49.1.15
Source DB: PubMed Journal: Anat Cell Biol ISSN: 2093-3665
The CK-MM concentrations before and after the walking test
| Group | Before the walking test (IU) | After the walking test (IU) | |
|---|---|---|---|
| Treatment | 70.07±15.33 | 77.86±19.68 | <0.001 |
| Control | 69.85±17.03 | 91.85±20.72 | <0.001 |
The paired t-test shows that the CK-MM concentrations increased significantly on both group. CK-MM, creatine kinase-MM; IU, International Unit.
Elevation of the CK-MM concentrations after the walking test
| Group | Elevation of the CK-MM concentration (IU) | |
|---|---|---|
| Treatment | 7.8±9 | 0.001 |
| Control | 22.0±11.5 |
The unpaired t test showed the elevation of the CK-MM concentrations after the walking test was higher significantly in the control group (P≤0.05). CK-MM, creatine kinase-MM; IU, International Unit.
Differences of the CK-MM concentrations before and 45 hours after the first, the second, and the third walking test on the treatment group
| Examination time | CK-MM concentration (IU) | |
|---|---|---|
| Before walking test | 70.07±15.33 | 0.018 |
| After the first walking test | 77.86±19.68 | |
| After the second walking test | 77.21±17.47 | |
| After the third walking test | 69.86±11.88 |
CK-MM, creatine kinase-MM; IU, International Unit.